“…Therefore, the administration of NRCl and its derivatives triggers altered expression of key BBM genes involved in digestion, and absorption, with additional effects on intestinal microbiota composition and function. Further and as was previously suggested, these functional changes, as demonstrated via gene expression of key BBM proteins (zinc transporter, inflammatory cytokines, absorptive proteins, and mucin), were previously associated with BBM tissue physiological and morphometric alterations, as increased villi size [ 24 , 50 , 93 , 94 , 95 , 96 , 97 ]. These alterations may potentially also be associated with increased proliferation of cellular populations that hold essential roles in BBM function, including, enterocytes, and therefore, increased villus surface area (the intestinal digestive and absorptive surface), and goblet cells (produce and secrete mucus), both number and diameter in intestinal villi and crypt [ 18 , 22 , 24 , 47 , 50 , 93 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 ].…”